• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

OIS subsidiary acquires Acermed Inc.'s assets

Article

Sacramento, CA-Ophthalmic Imaging Systems (OIS) acquired substantially all of the assets of Acermed, Inc., which was done through OIS' new subsidiary, Abraxas Medical Solutions Inc., and was approved by the California Central Bankruptcy Court. Terms of the transaction were not disclosed.

Sacramento, CA-Ophthalmic Imaging Systems (OIS) acquired substantially all of the assets of Acermed, Inc., which was done through OIS' new subsidiary, Abraxas Medical Solutions Inc., and was approved by the California Central Bankruptcy Court. Terms of the transaction were not disclosed.

AcerMed software automates the clinical, administrative, and financial operations of a medical office. The software has been certified by the Center for Certification of Health Information Technology.

AcerMed's former Chief Executive Officer Michael A. Bina has been named president of Abraxas. Seven former employees of AcerMed have signed employment agreements with Abraxas. OIS anticipates investing $2 million on the expansion of operations of Abraxas in all departments, including R&D, technical support, and sales.

"We are excited to expand upon our current line of informatics offerings through the acquisition of AcerMed's assets and are confident in our ability to further penetrate the growing market for EMR and Practice Management software solutions. This acquisition allows us to broaden our reach into new markets beyond our current offering of informatics platform to ophthalmologists," said Gil Allon, CEO of OIS. "On behalf of the company, I would like to welcome Mike and his team to OIS."

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.